Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

Journal: Nature Communications

Published: 2018-09-06

DOI: 10.1038/s41467-018-06067-7

Affiliations: 13

Authors: 25

Go to article
Institutions FC
Department of Epigenetics and Molecular Carcinogenesis, MD Anderson Cancer Center, United States of America (USA) 0.43
Department of Pharmacology and Therapeutics, RPCI, United States of America (USA) 0.21
Department of Medicine, RPCI, United States of America (USA) 0.08
Duke Department of Pathology, United States of America (USA) 0.04
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0.04
Sandra and Edward Meyer Cancer Center, Cornell University, United States of America (USA) 0.04
Department of Urology, RPCI, United States of America (USA) 0.04
Department of Biostatistics and Bioinformatics, RPCI, United States of America (USA) 0.04
Graduate School of Biomedical Sciences, UMass Medical School, United States of America (USA) 0.03
Tongji Hospital (TJH), HUST, China 0.01
Shanghai East Hospital, Tongji University, China 0.01
State Key Laboratory Breeding Base of Basic Science of Stomatology, WHU, China 0.01
MOE Key Laboratory of Oral Biomedicine, WHU, China 0.01

Return